Transplacental Transfer and Biotransformation of Genistein in Human Placenta

Placenta

Volumn 31, Issue 6, 2010, Pages 506-511

  Balakrishnan, B ^a,b   Thorstensen, E B ^a,b   Ponnampalam, A P ^a   Mitchell, M D ^a,b,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Endocrine disruptors; Genistein; Genistein glucuronide; Phytoestrogens; Placental perfusion; Placental transfer

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GENISTEIN; GLUCURONIDE; PHENAZONE; SULFATE;

ARTICLE; CONTROLLED STUDY; DRUG CONCENTRATION; DRUG CONJUGATION; DRUG STRUCTURE; DRUG TRANSFORMATION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NORMAL HUMAN; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRIORITY JOURNAL; VALIDATION STUDY;

BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENISTEIN; HUMANS; MATERNAL-FETAL EXCHANGE; PHYTOESTROGENS; PLACENTA; PREGNANCY; TANDEM MASS SPECTROMETRY;

EID: 77952549105     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.03.007     Document Type: Article

References (50)

1. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect 103 Suppl. 7 (1995) 83-87
2. Colborn T., vom Saal F.S., and Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101 5 (1993) 378-384
3. vom Saal F.S., Cooke P.S., Buchanan D.L., Palanza P., Thayer K.A., Nagel S.C., et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health 14 1-2 (1998) 239-260
4. Ravindranath M.H., Muthugounder S., Presser N., and Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 546 (2004) 121-165
5. Albertazzi P. Purified phytoestrogens in postmenopausal bone health: is there a role for genistein?. Climacteric 5 2 (2002) 190-196
6. Orgaard A., and Jensen L. The effects of soy isoflavones on obesity. Exp Biol Med (Maywood) 233 9 (2008) 1066-1080
7. Klein C.B., and King A.A. Genistein genotoxicity: critical considerations of in vitro exposure dose. Toxicol Appl Pharmacol 224 1 (2007) 1-11
8. Folman Y., and Pope G.S. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 34 2 (1966) 215-225
9. Lamartiniere C.A., Cotroneo M.S., Fritz W.A., Wang J., Mentor-Marcel R., and Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 132 3 (2002) 552S-558S
10. Warri A., Saarinen N.M., Makela S., and Hilakivi-Clarke L. The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer 98 9 (2008) 1485-1493
11. Doerge D.R., Churchwell M.I., Chang H.C., Newbold R.R., and Delclos K.B. Placental transfer of the soy isoflavone genistein following dietary and gavage administration to Sprague Dawley rats. Reprod Toxicol 15 2 (2001) 105-110
12. Soucy N.V., Parkinson H.D., Sochaski M.A., and Borghoff S.J. Kinetics of genistein and its conjugated metabolites in pregnant Sprague-Dawley rats following single and repeated genistein administration. Toxicol Sci 90 1 (2006) 230-240
13. Wisniewski A.B., Klein S.L., Lakshmanan Y., and Gearhart J.P. Exposure to genistein during gestation and lactation demasculinizes the reproductive system in rats. J Urol 169 4 (2003) 1582-1586
14. Newbold R.R., Banks E.P., Bullock B., and Jefferson W.N. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 61 11 (2001) 4325-4328
15. Jefferson W.N., Padilla-Banks E., and Newbold R.R. Disruption of the developing female reproductive system by phytoestrogens: genistein as an example. Mol Nutr Food Res 51 7 (2007) 832-844
16. Jefferson W.N., Padilla-Banks E., and Newbold R.R. Disruption of the female reproductive system by the phytoestrogen genistein. Reprod Toxicol 23 3 (2007) 308-316
17. Latendresse J.R., Bucci T.J., Olson G., Mellick P., Weis C.C., Thorn B., et al. Genistein and ethinyl estradiol dietary exposure in multigenerational and chronic studies induce similar proliferative lesions in mammary gland of male Sprague-Dawley rats. Reprod Toxicol 28 3 (2009) 342-353
18. Richter D.U., Mylonas I., Toth B., Scholz C., Briese V., Friese K., et al. Effects of phytoestrogens genistein and daidzein on progesterone and estrogen (estradiol) production of human term trophoblast cells in vitro. Gynecol Endocrinol 25 1 (2009) 32-38
19. Jeschke U., Briese V., Richter D.U., Bruer G., Plessow D., Waldschlager J., et al. Effects of phytoestrogens genistein and daidzein on production of human chorionic gonadotropin in term trophoblast cells in vitro. Gynecol Endocrinol 21 3 (2005) 180-184
20. North K., and Golding J. A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon longitudinal study of pregnancy and childhood. BJU Int 85 1 (2000) 107-113
21. Ross J.A., and Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22 (2002) 19-34
22. Adlercreutz H., Yamada T., Wahala K., and Watanabe S. Maternal and neonatal phytoestrogens in Japanese women during birth. Am J Obstet Gynecol 180 3 Pt 1 (1999) 737-743
23. Foster W.G., Chan S., Platt L., and Hughes Jr. C.L. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol Lett 129 3 (2002) 199-205
24. Engel S.M., Levy B., Liu Z., Kaplan D., and Wolff M.S. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol 21 1 (2006) 110-112
25. Todaka E., Sakurai K., Fukata H., Miyagawa H., Uzuki M., Omori M., et al. Fetal exposure to phytoestrogens - the difference in phytoestrogen status between mother and fetus. Environ Res 99 2 (2005) 195-203
26. Mustafa A.M., Malintan N.T., Seelan S., Zhan Z., Mohamed Z., Hassan J., et al. Phytoestrogens levels determination in the cord blood from Malaysia rural and urban populations. Toxicol Appl Pharmacol 222 1 (2007) 25-32
27. Doerge D.R., Chang H.C., Churchwell M.I., and Holder C.L. Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos 28 3 (2000) 298-307
28. Ala-Kokko T.I., Pienimaki P., Herva R., Hollmen A.I., Pelkonen O., and Vahakangas K. Transfer of lidocaine and bupivacaine across the isolated perfused human placenta. Pharmacol Toxicol 77 2 (1995) 142-148
29. Collier A.C., Keelan J.A., Van Zijl P.E., Paxton J.W., Mitchell M.D., and Tingle M.D. Human placental glucuronidation and transport of 3′azido-3′-deoxythymidine and uridine diphosphate glucuronic acid. Drug Metab Dispos 32 8 (2004) 813-820
30. Balakrishnan B., Henare K., Thorstensen E.B., Ponnampalam A.P., and Mitchell M.D. Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 202 4 (2010) 393 e1-7
31. Cannell G.R., Kluck R.M., Hamilton S.E., Mortimer R.H., Hooper W.D., and Dickinson R.G. Markers of physical integrity and metabolic viability of the perfused human placental lobule. Clin Exp Pharmacol Physiol 15 11 (1988) 837-844
32. Glance D.G., Elder M.G., Bloxam D.L., and Myatt L. The effects of the components of the renin-angiotensin system on the isolated perfused human placental cotyledon. Am J Obstet Gynecol 149 4 (1984) 450-454
33. Miller R.K., Mace K., Polliotti B., DeRita R., Hall W., and Treacy G. Marginal transfer of ReoPro (Abciximab) compared with immunoglobulin G (F105), inulin and water in the perfused human placenta in vitro. Placenta 24 7 (2003) 727-738
34. Kraemer J., Klein J., Lubetsky A., and Koren G. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 195 1 (2006) 270-274
35. Pimentel G., Figueroa J.P., Mitchell M.D., Massmann A., and Nathanielsz P.W. Effect of fetal and maternal intravascular antipyrine infusion on maternal plasma prostaglandin concentrations in the pregnant sheep at 104 to 127 days' gestation. Am J Obstet Gynecol 155 6 (1986) 1181-1185
36. Matsumoto A., Kunugita N., Kitagawa K., Isse T., Oyama T., Foureman G.L., et al. Bisphenol A levels in human urine. Environ Health Perspect 111 1 (2003) 101-104
37. Myllynen P., and Vahakangas K. An examination of whether human placental perfusion allows accurate prediction of placental drug transport: studies with diazepam. J Pharmacol Toxicol Methods 48 3 (2002) 131-138
38. Imai Y., Tsukahara S., Asada S., and Sugimoto Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 64 12 (2004) 4346-4352
39. Yeboah D., Sun M., Kingdom J., Baczyk D., Lye S.J., Matthews S.G., et al. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol 84 12 (2006) 1251-1258
40. Evseenko D.A., Paxton J.W., and Keelan J.A. ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am J Physiol Regul Integr Comp Physiol 290 5 (2006) R1357-R1365
41. Enokizono J., Kusuhara H., and Sugiyama Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 72 4 (2007) 967-975
42. Evseenko D., Paxton J.W., and Keelan J.A. Active transport across the human placenta: impact on drug efficacy and toxicity. Expert Opin Drug Metab Toxicol 2 1 (2006) 51-69
43. Mathias A.A., Hitti J., and Unadkat J.D. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 289 4 (2005) R963-R969
44. Tang L., Singh R., Liu Z., and Hu M. Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm 6 5 (2009) 1466-1482
45. Syme M.R., Paxton J.W., and Keelan J.A. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 43 8 (2004) 487-514
46. Collier A.C., Ganley N.A., Tingle M.D., Blumenstein M., Marvin K.W., Paxton J.W., et al. UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term. Biochem Pharmacol 63 3 (2002) 409-419
47. Collier A.C., Tingle M.D., Paxton J.W., Mitchell M.D., and Keelan J.A. Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption. Hum Reprod 17 10 (2002) 2564-2572
48. Heroux J.A., Falany C.N., and Roth J.A. Immunological characterization of human phenol sulfotransferase. Mol Pharmacol 36 1 (1989) 29-33
49. Matsumoto J., Yokota H., and Yuasa A. Developmental increases in rat hepatic microsomal UDP-glucuronosyltransferase activities toward xenoestrogens and decreases during pregnancy. Environ Health Perspect 110 2 (2002) 193-196
50. Coughtrie M.W., Burchell B., Leakey J.E., and Hume R. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 34 6 (1988) 729-735